Molecular mechanism of SARS-CoV-2 cell entry inhibition via TMPRSS2 by Camostat and Nafamostat mesylate
T. Hempel, L. Raich, S. Olsson, N. P. Azouz, A. M. Klingler, M. E. Rothenberg, F. Noe
This study investigates how camostat and nafamostat inhibit SARS-CoV-2 entry by targeting TMPRSS2 through molecular simulations and experiments, showing nafamostat's higher efficacy due to increased Michaelis complex binding.
Chemical Science · Jan 1, 2021Peer-reviewedBiophysics